Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
As filed with the Securities and Exchange Commission on March 5, 2020 Registration No. 333- ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form...
Zafgen and Chondrial Therapeutics previously announced a definitive merger agreement Merger creates...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE...
CUSIP No. 98885E103 Page 1 of 6 UNITED...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.